Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis, Chronic | 18 | 2024 | 285 | 9.020 |
Why?
|
Pancreatitis | 21 | 2023 | 1092 | 7.480 |
Why?
|
Pancreatic Function Tests | 5 | 2017 | 69 | 2.300 |
Why?
|
Exocrine Pancreatic Insufficiency | 3 | 2024 | 80 | 1.730 |
Why?
|
Secretin | 3 | 2017 | 57 | 1.660 |
Why?
|
Pancreatitis, Alcoholic | 2 | 2022 | 30 | 1.620 |
Why?
|
Acute Disease | 19 | 2024 | 7149 | 1.540 |
Why?
|
Endoscopy, Gastrointestinal | 15 | 2023 | 868 | 1.330 |
Why?
|
Colonoscopy | 7 | 2022 | 1367 | 1.300 |
Why?
|
Alcoholism | 4 | 2022 | 1906 | 1.280 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2022 | 632 | 1.180 |
Why?
|
Lipase | 2 | 2021 | 314 | 1.160 |
Why?
|
Gallstones | 3 | 2022 | 286 | 1.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 8 | 2023 | 504 | 1.020 |
Why?
|
Pancreas | 5 | 2023 | 1686 | 1.020 |
Why?
|
Gastroenterology | 6 | 2016 | 536 | 0.900 |
Why?
|
Choledocholithiasis | 1 | 2022 | 48 | 0.810 |
Why?
|
Adenoma | 5 | 2022 | 2174 | 0.800 |
Why?
|
Pancreatic Neoplasms | 4 | 2022 | 5256 | 0.790 |
Why?
|
Colonic Polyps | 5 | 2022 | 542 | 0.780 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2023 | 360 | 0.740 |
Why?
|
Bone Diseases, Metabolic | 1 | 2023 | 417 | 0.670 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 426 | 0.660 |
Why?
|
Restless Legs Syndrome | 1 | 2022 | 228 | 0.660 |
Why?
|
Pancreatic Juice | 1 | 2017 | 62 | 0.600 |
Why?
|
Endosonography | 2 | 2020 | 610 | 0.590 |
Why?
|
Critical Pathways | 2 | 2018 | 476 | 0.590 |
Why?
|
Bicarbonates | 1 | 2017 | 313 | 0.560 |
Why?
|
Opioid-Related Disorders | 2 | 2022 | 2065 | 0.550 |
Why?
|
Analgesics, Opioid | 7 | 2022 | 3674 | 0.530 |
Why?
|
Colorectal Neoplasms | 5 | 2022 | 6773 | 0.530 |
Why?
|
Quality Indicators, Health Care | 3 | 2023 | 1831 | 0.530 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1076 | 0.490 |
Why?
|
Publications | 1 | 2017 | 195 | 0.480 |
Why?
|
Watchful Waiting | 1 | 2018 | 492 | 0.480 |
Why?
|
Length of Stay | 6 | 2023 | 6309 | 0.480 |
Why?
|
Hypertension, Portal | 4 | 1996 | 220 | 0.470 |
Why?
|
Peer Review, Research | 1 | 2017 | 329 | 0.460 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2022 | 1634 | 0.460 |
Why?
|
Osteoporosis | 1 | 2023 | 1580 | 0.450 |
Why?
|
Clinical Competence | 5 | 2020 | 4687 | 0.440 |
Why?
|
Curriculum | 8 | 2021 | 3605 | 0.430 |
Why?
|
Pilot Projects | 7 | 2023 | 8324 | 0.430 |
Why?
|
Humans | 103 | 2024 | 744343 | 0.420 |
Why?
|
Cholestasis | 3 | 2023 | 378 | 0.400 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2016 | 437 | 0.390 |
Why?
|
Fractures, Bone | 1 | 2023 | 1947 | 0.380 |
Why?
|
Patient Discharge | 1 | 2023 | 3313 | 0.360 |
Why?
|
Retrospective Studies | 17 | 2023 | 77449 | 0.340 |
Why?
|
Hospitalization | 5 | 2023 | 10262 | 0.330 |
Why?
|
Cholecystectomy | 2 | 2020 | 395 | 0.310 |
Why?
|
Hepatitis, Chronic | 1 | 2006 | 52 | 0.290 |
Why?
|
Cholangitis, Sclerosing | 2 | 2011 | 159 | 0.290 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.290 |
Why?
|
Risk Factors | 15 | 2024 | 72290 | 0.280 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7659 | 0.270 |
Why?
|
Critical Illness | 2 | 2017 | 2670 | 0.270 |
Why?
|
Periodicals as Topic | 1 | 2017 | 1432 | 0.260 |
Why?
|
Meningitis, Fungal | 1 | 2024 | 4 | 0.250 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 611 | 0.240 |
Why?
|
Practice Guidelines as Topic | 7 | 2019 | 7279 | 0.240 |
Why?
|
Fusarium | 1 | 2024 | 51 | 0.240 |
Why?
|
Middle Aged | 34 | 2023 | 213383 | 0.230 |
Why?
|
Liver Cirrhosis | 3 | 2006 | 1863 | 0.230 |
Why?
|
Stomach Neoplasms | 2 | 2023 | 1333 | 0.230 |
Why?
|
Patient Readmission | 3 | 2023 | 3114 | 0.230 |
Why?
|
Male | 47 | 2023 | 350118 | 0.230 |
Why?
|
Diagnostic Imaging | 2 | 2015 | 3507 | 0.230 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1583 | 0.230 |
Why?
|
Pancreatic Hormones | 1 | 2022 | 13 | 0.220 |
Why?
|
Review Literature as Topic | 2 | 2023 | 336 | 0.220 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2002 | 41 | 0.220 |
Why?
|
Abdominal Pain | 2 | 2023 | 1063 | 0.220 |
Why?
|
Chloride Channels | 2 | 2004 | 227 | 0.220 |
Why?
|
Female | 41 | 2023 | 380194 | 0.220 |
Why?
|
Adult | 37 | 2022 | 214055 | 0.220 |
Why?
|
Recurrence | 5 | 2022 | 8340 | 0.220 |
Why?
|
Celiac Disease | 4 | 2011 | 785 | 0.210 |
Why?
|
Gastric Balloon | 1 | 2022 | 31 | 0.210 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2022 | 109 | 0.200 |
Why?
|
Biliary Tract Diseases | 1 | 2002 | 161 | 0.200 |
Why?
|
Liver Transplantation | 2 | 2023 | 2119 | 0.200 |
Why?
|
Helicobacter pylori | 3 | 2009 | 382 | 0.190 |
Why?
|
Acetylation | 1 | 2023 | 1085 | 0.190 |
Why?
|
Predictive Value of Tests | 5 | 2017 | 15076 | 0.190 |
Why?
|
Iatrogenic Disease | 1 | 2024 | 547 | 0.190 |
Why?
|
Chlorides | 1 | 2003 | 667 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
Lung Diseases, Obstructive | 1 | 2001 | 316 | 0.180 |
Why?
|
Inpatients | 2 | 2022 | 2518 | 0.180 |
Why?
|
Prescriptions | 1 | 2022 | 387 | 0.180 |
Why?
|
Esophageal Achalasia | 1 | 2021 | 91 | 0.180 |
Why?
|
Guidelines as Topic | 2 | 2017 | 1405 | 0.170 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2021 | 118 | 0.170 |
Why?
|
Pain, Postoperative | 2 | 2022 | 1643 | 0.170 |
Why?
|
Time Factors | 9 | 2022 | 40075 | 0.170 |
Why?
|
Early Diagnosis | 2 | 2015 | 1184 | 0.170 |
Why?
|
Gallbladder Neoplasms | 1 | 2000 | 183 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.160 |
Why?
|
Quality of Life | 4 | 2024 | 12804 | 0.160 |
Why?
|
Megacolon, Toxic | 1 | 1998 | 7 | 0.160 |
Why?
|
Prospective Studies | 13 | 2020 | 53288 | 0.160 |
Why?
|
Collateral Circulation | 2 | 1996 | 287 | 0.160 |
Why?
|
Preventive Medicine | 1 | 2000 | 264 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2018 | 5078 | 0.150 |
Why?
|
Duodenum | 3 | 2017 | 483 | 0.150 |
Why?
|
Encephalitozoonosis | 1 | 1997 | 2 | 0.150 |
Why?
|
Encephalitozoon | 1 | 1997 | 5 | 0.150 |
Why?
|
Stents | 4 | 2023 | 3280 | 0.150 |
Why?
|
Endoscopes, Gastrointestinal | 1 | 2017 | 60 | 0.150 |
Why?
|
Bile Ducts | 2 | 2011 | 284 | 0.150 |
Why?
|
Pain | 2 | 2022 | 4986 | 0.150 |
Why?
|
Conflict of Interest | 4 | 2014 | 544 | 0.140 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 1996 | 66 | 0.140 |
Why?
|
Portal System | 1 | 1996 | 52 | 0.140 |
Why?
|
Endoscopy | 4 | 2021 | 1785 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2023 | 2282 | 0.140 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39050 | 0.140 |
Why?
|
Aspartate Aminotransferases | 1 | 1998 | 418 | 0.140 |
Why?
|
Aged | 20 | 2021 | 163280 | 0.140 |
Why?
|
Hepatic Encephalopathy | 1 | 1997 | 139 | 0.140 |
Why?
|
Severity of Illness Index | 4 | 2023 | 15540 | 0.130 |
Why?
|
Body Fluids | 1 | 2017 | 319 | 0.130 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6364 | 0.130 |
Why?
|
Diazinon | 1 | 1995 | 4 | 0.130 |
Why?
|
Glycoproteins | 1 | 2023 | 2263 | 0.130 |
Why?
|
Splenomegaly | 1 | 1996 | 190 | 0.130 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1990 | 0.130 |
Why?
|
Capnography | 1 | 2016 | 89 | 0.130 |
Why?
|
Alanine Transaminase | 1 | 1998 | 592 | 0.130 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1107 | 0.130 |
Why?
|
Smoking | 2 | 2023 | 8987 | 0.130 |
Why?
|
Hepatitis | 1 | 1997 | 227 | 0.130 |
Why?
|
United States | 10 | 2023 | 69872 | 0.120 |
Why?
|
Helicobacter Infections | 2 | 2009 | 386 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 2017 | 350 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1142 | 0.120 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2006 | 2214 | 0.120 |
Why?
|
Disease Outbreaks | 1 | 2024 | 1772 | 0.120 |
Why?
|
Colonic Diseases | 1 | 2016 | 202 | 0.120 |
Why?
|
Midazolam | 1 | 2016 | 270 | 0.120 |
Why?
|
Counseling | 1 | 2022 | 1523 | 0.120 |
Why?
|
Cystic Fibrosis | 3 | 2016 | 1177 | 0.120 |
Why?
|
Paralysis | 1 | 1995 | 247 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 657 | 0.110 |
Why?
|
Evidence-Based Medicine | 3 | 2014 | 3610 | 0.110 |
Why?
|
Insecticides | 1 | 1995 | 195 | 0.110 |
Why?
|
Cholinesterase Inhibitors | 1 | 1995 | 238 | 0.110 |
Why?
|
Fentanyl | 1 | 2016 | 410 | 0.110 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14722 | 0.110 |
Why?
|
Nose | 1 | 2016 | 509 | 0.110 |
Why?
|
Bronchial Diseases | 1 | 2014 | 151 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12245 | 0.110 |
Why?
|
Gastrointestinal Agents | 1 | 2017 | 494 | 0.110 |
Why?
|
Pain Measurement | 2 | 2020 | 3420 | 0.110 |
Why?
|
Workflow | 1 | 2017 | 847 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2001 | 1170 | 0.110 |
Why?
|
Pesticides | 1 | 1995 | 287 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 764 | 0.100 |
Why?
|
Gastric Mucosa | 2 | 2021 | 599 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2029 | 0.100 |
Why?
|
Pulmonary Medicine | 1 | 2014 | 213 | 0.100 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 503 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2013 | 302 | 0.100 |
Why?
|
Pneumothorax | 1 | 1995 | 379 | 0.100 |
Why?
|
Societies, Medical | 4 | 2017 | 3743 | 0.100 |
Why?
|
Conscious Sedation | 1 | 2016 | 528 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2022 | 1213 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4253 | 0.100 |
Why?
|
Blood Coagulation | 1 | 1996 | 1127 | 0.090 |
Why?
|
Pancreatectomy | 1 | 2015 | 804 | 0.090 |
Why?
|
Air | 1 | 2010 | 182 | 0.090 |
Why?
|
Mesalamine | 1 | 2011 | 136 | 0.090 |
Why?
|
Nephrology | 1 | 2014 | 263 | 0.090 |
Why?
|
Bone Density | 1 | 2023 | 3468 | 0.090 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 639 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2021 | 21746 | 0.090 |
Why?
|
Benchmarking | 1 | 2016 | 1042 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 1998 | 1031 | 0.090 |
Why?
|
Rectal Diseases | 1 | 2010 | 143 | 0.090 |
Why?
|
Prognosis | 4 | 2023 | 29063 | 0.080 |
Why?
|
Incidence | 4 | 2021 | 20947 | 0.080 |
Why?
|
Colon | 3 | 2010 | 1772 | 0.080 |
Why?
|
Spleen | 1 | 1995 | 2362 | 0.080 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2759 | 0.080 |
Why?
|
Critical Care | 1 | 2001 | 2647 | 0.080 |
Why?
|
Internal Medicine | 1 | 2015 | 1009 | 0.080 |
Why?
|
Patient Care | 1 | 2013 | 640 | 0.080 |
Why?
|
Insulin | 1 | 2022 | 6580 | 0.080 |
Why?
|
Irritable Bowel Syndrome | 1 | 2013 | 445 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1924 | 0.070 |
Why?
|
Urease | 1 | 2007 | 42 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3158 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2008 | 281 | 0.070 |
Why?
|
Docosahexaenoic Acids | 2 | 2011 | 875 | 0.070 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2017 | 19905 | 0.070 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 331 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12354 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 1996 | 2645 | 0.070 |
Why?
|
Phototherapy | 1 | 2009 | 377 | 0.070 |
Why?
|
Sleep | 1 | 2022 | 4623 | 0.070 |
Why?
|
Breath Tests | 1 | 2007 | 280 | 0.070 |
Why?
|
Bone Marrow | 1 | 1996 | 2948 | 0.070 |
Why?
|
Internship and Residency | 3 | 2021 | 5788 | 0.070 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5319 | 0.070 |
Why?
|
Patient Care Team | 1 | 2017 | 2531 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18370 | 0.070 |
Why?
|
Liver | 3 | 2011 | 7474 | 0.060 |
Why?
|
Ultrasonography | 5 | 2020 | 5985 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 12959 | 0.060 |
Why?
|
Hemostatic Techniques | 1 | 2005 | 116 | 0.060 |
Why?
|
Drug Resistance, Fungal | 1 | 2024 | 52 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2013 | 2425 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57776 | 0.060 |
Why?
|
Administration, Rectal | 1 | 2023 | 73 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3749 | 0.060 |
Why?
|
Esophageal and Gastric Varices | 2 | 1996 | 207 | 0.060 |
Why?
|
Nasal Mucosa | 2 | 2004 | 373 | 0.060 |
Why?
|
Immunocompetence | 1 | 2024 | 137 | 0.060 |
Why?
|
Sweat | 1 | 2003 | 49 | 0.060 |
Why?
|
Foreign-Body Migration | 1 | 2005 | 222 | 0.060 |
Why?
|
Aspirin | 1 | 2015 | 3282 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2023 | 63114 | 0.060 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2003 | 97 | 0.050 |
Why?
|
Cohort Studies | 3 | 2021 | 40561 | 0.050 |
Why?
|
Common Bile Duct | 1 | 2002 | 109 | 0.050 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2002 | 111 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5751 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3086 | 0.050 |
Why?
|
Cholecystitis | 1 | 2002 | 182 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2014 | 4577 | 0.050 |
Why?
|
Mexico | 1 | 2024 | 690 | 0.050 |
Why?
|
Analgesia, Epidural | 1 | 2024 | 327 | 0.050 |
Why?
|
Mutation | 3 | 2004 | 29786 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13989 | 0.050 |
Why?
|
Crohn Disease | 1 | 2013 | 2303 | 0.040 |
Why?
|
Tacrolimus | 1 | 2023 | 743 | 0.040 |
Why?
|
Image Enhancement | 1 | 2010 | 2921 | 0.040 |
Why?
|
Budesonide | 2 | 2011 | 154 | 0.040 |
Why?
|
Dissection | 1 | 2021 | 295 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2024 | 730 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2011 | 3297 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4217 | 0.040 |
Why?
|
Posture | 1 | 2023 | 958 | 0.040 |
Why?
|
Internationality | 1 | 2024 | 1003 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9146 | 0.040 |
Why?
|
Clinical Enzyme Tests | 1 | 1998 | 115 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2005 | 1130 | 0.040 |
Why?
|
Disclosure | 2 | 2014 | 736 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 817 | 0.040 |
Why?
|
Biopsy | 2 | 2001 | 6756 | 0.040 |
Why?
|
Contrast Media | 1 | 2010 | 5300 | 0.040 |
Why?
|
Cholangiocarcinoma | 1 | 2002 | 516 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2133 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
Endoscopy, Digestive System | 1 | 2019 | 345 | 0.040 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1996 | 65 | 0.030 |
Why?
|
Delphi Technique | 1 | 2019 | 778 | 0.030 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2291 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2009 | 3748 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2008 | 3690 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2019 | 723 | 0.030 |
Why?
|
Colitis | 1 | 2004 | 1170 | 0.030 |
Why?
|
Action Potentials | 1 | 2003 | 1806 | 0.030 |
Why?
|
Pralidoxime Compounds | 1 | 1995 | 5 | 0.030 |
Why?
|
Cholinesterase Reactivators | 1 | 1995 | 6 | 0.030 |
Why?
|
Fasciculation | 1 | 1995 | 8 | 0.030 |
Why?
|
Alkaline Phosphatase | 2 | 2011 | 865 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 593 | 0.030 |
Why?
|
Atropine | 1 | 1995 | 244 | 0.030 |
Why?
|
Chest Tubes | 1 | 1995 | 150 | 0.030 |
Why?
|
Resuscitation | 1 | 2019 | 658 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1995 | 192 | 0.030 |
Why?
|
Employment | 1 | 2021 | 1132 | 0.030 |
Why?
|
Myxoma | 1 | 1995 | 130 | 0.030 |
Why?
|
Muscarinic Antagonists | 1 | 1995 | 137 | 0.030 |
Why?
|
Portal Vein | 1 | 1996 | 437 | 0.030 |
Why?
|
Quadriplegia | 1 | 1995 | 223 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2001 | 1403 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 1681 | 0.030 |
Why?
|
Ciliary Motility Disorders | 1 | 1993 | 47 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11366 | 0.030 |
Why?
|
Massachusetts | 2 | 2016 | 8663 | 0.030 |
Why?
|
Liver Diseases | 1 | 2001 | 1253 | 0.030 |
Why?
|
Bronchiectasis | 1 | 1993 | 128 | 0.030 |
Why?
|
Arteriovenous Malformations | 1 | 1995 | 396 | 0.030 |
Why?
|
Family Practice | 1 | 2015 | 516 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 1996 | 2031 | 0.030 |
Why?
|
Biopsy, Needle | 2 | 2011 | 1641 | 0.020 |
Why?
|
Hematocrit | 1 | 2013 | 636 | 0.020 |
Why?
|
Heart Neoplasms | 1 | 1995 | 374 | 0.020 |
Why?
|
Risk Assessment | 3 | 2019 | 23338 | 0.020 |
Why?
|
Prevalence | 2 | 2009 | 15226 | 0.020 |
Why?
|
Administration, Oral | 2 | 2011 | 3913 | 0.020 |
Why?
|
Geriatrics | 1 | 2015 | 396 | 0.020 |
Why?
|
Genetic Testing | 1 | 2003 | 3444 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2011 | 528 | 0.020 |
Why?
|
Disease Progression | 1 | 2006 | 13284 | 0.020 |
Why?
|
Fibrosis | 1 | 1996 | 2029 | 0.020 |
Why?
|
Sex Distribution | 1 | 1995 | 2297 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 1995 | 672 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2214 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2016 | 957 | 0.020 |
Why?
|
Age Distribution | 1 | 1995 | 2902 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1998 | 6365 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 12951 | 0.020 |
Why?
|
Dehydration | 1 | 2010 | 234 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1420 | 0.020 |
Why?
|
Pneumonectomy | 1 | 1995 | 1094 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2016 | 1162 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2015 | 2453 | 0.020 |
Why?
|
Genetic Variation | 1 | 2003 | 6544 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 1998 | 2716 | 0.020 |
Why?
|
Reference Values | 1 | 1995 | 4982 | 0.020 |
Why?
|
Heterozygote | 2 | 2004 | 2804 | 0.020 |
Why?
|
Duodenoscopy | 1 | 2007 | 52 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
Child, Preschool | 3 | 2016 | 41006 | 0.020 |
Why?
|
Spinal Cord | 1 | 1995 | 1809 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1880 | 0.020 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1008 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 1993 | 961 | 0.020 |
Why?
|
Phenotype | 1 | 2003 | 16365 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2010 | 650 | 0.020 |
Why?
|
Adolescent | 4 | 2016 | 85781 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 21827 | 0.020 |
Why?
|
Gastroscopy | 1 | 2007 | 207 | 0.020 |
Why?
|
Patients | 1 | 2012 | 900 | 0.020 |
Why?
|
Steroids | 1 | 2010 | 930 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2266 | 0.020 |
Why?
|
Intestine, Small | 1 | 2011 | 1241 | 0.020 |
Why?
|
Europe | 1 | 2011 | 3339 | 0.020 |
Why?
|
Isoproterenol | 1 | 2004 | 399 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2010 | 814 | 0.010 |
Why?
|
Infant | 2 | 2016 | 35136 | 0.010 |
Why?
|
Consensus | 1 | 2013 | 2959 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 2004 | 236 | 0.010 |
Why?
|
Malnutrition | 1 | 2010 | 625 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3396 | 0.010 |
Why?
|
Ion Transport | 1 | 2004 | 320 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 1995 | 8642 | 0.010 |
Why?
|
Headache | 1 | 2011 | 1226 | 0.010 |
Why?
|
Equipment Failure | 1 | 2005 | 578 | 0.010 |
Why?
|
Young Adult | 3 | 2016 | 56430 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2007 | 1150 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2008 | 1171 | 0.010 |
Why?
|
Stomach | 1 | 2007 | 697 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9313 | 0.010 |
Why?
|
Child | 3 | 2016 | 77709 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2107 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2004 | 1137 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3870 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7181 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1470 | 0.010 |
Why?
|
Animals | 3 | 2023 | 168757 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1790 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3923 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2751 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81183 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1785 | 0.010 |
Why?
|
Sodium | 1 | 2004 | 1623 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3309 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12788 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2003 | 2110 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1995 | 25625 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2008 | 3848 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3336 | 0.010 |
Why?
|
Angiography, Digital Subtraction | 1 | 1995 | 341 | 0.010 |
Why?
|
Rupture | 1 | 1995 | 433 | 0.010 |
Why?
|
Cell Line | 1 | 2008 | 15997 | 0.010 |
Why?
|
Oligospermia | 1 | 1993 | 59 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9438 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1995 | 20129 | 0.010 |
Why?
|
Diet | 1 | 2010 | 7939 | 0.010 |
Why?
|
Veins | 1 | 1995 | 770 | 0.010 |
Why?
|
Neck | 1 | 1995 | 697 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2004 | 14557 | 0.010 |
Why?
|
Heart Atria | 1 | 1995 | 1357 | 0.010 |
Why?
|
Laparoscopy | 1 | 2001 | 2151 | 0.010 |
Why?
|
Palliative Care | 1 | 2003 | 3493 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1995 | 1257 | 0.000 |
Why?
|
Syndrome | 1 | 1993 | 3251 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1995 | 1073 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2009 | 15295 | 0.000 |
Why?
|
Hypertension, Pulmonary | 1 | 1995 | 1537 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 1995 | 35421 | 0.000 |
Why?
|